Transfusion protocol for implantation and explantation of cardiac devices in an academic medical center

Angela N. Bartley, Daniel T Redford, Mary P. Berg

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Few reports in the literature describe the transfusion support needed for implantation and explantation of cardiac assist devices. Because such devices are frequently used at this institution, we have established a protocol to support these patients. We reviewed blood bank records to document the usage of blood components in all patients on cardiac assist devices from 1989 to 2005 (n = 215). The data were separated into components given at the time of implantation and explantation of the device. Implantation data on 214 patients showed the mean use as follows: red blood cells (RBC), 5.7 U; platelets (PLT), 2.4 U; fresh frozen plasma (FFP), 7.5 U; and cryoprecipitate, 0 U. Explantation data on 134 patients showed a mean use as follows: RBC, 7.7 U; PLT, 2.4 U; FFP, 9.9 U; and cryoprecipitate, 3.7 U. Our protocol for the preparation of blood components for implantation and explantation of a cardiac device is, implantation: RBC, 4 U; PLT, 1 U; FFP, 6 U; explantation: RBC, 8 U; PLT, 2 U; FFP, 8 U. Our data do not support the need for preparation of cryoprecipitate before implantation or explantation.

Original languageEnglish (US)
Pages (from-to)320-323
Number of pages4
JournalASAIO Journal
Volume53
Issue number3
DOIs
StatePublished - May 2007

Fingerprint

Blood
Equipment and Supplies
Blood Platelets
Erythrocytes
Platelets
Plasmas
Blood Banks
Cells

ASJC Scopus subject areas

  • Biophysics
  • Bioengineering

Cite this

Transfusion protocol for implantation and explantation of cardiac devices in an academic medical center. / Bartley, Angela N.; Redford, Daniel T; Berg, Mary P.

In: ASAIO Journal, Vol. 53, No. 3, 05.2007, p. 320-323.

Research output: Contribution to journalArticle

@article{39268b8c6079462da301ad3944a8d64e,
title = "Transfusion protocol for implantation and explantation of cardiac devices in an academic medical center",
abstract = "Few reports in the literature describe the transfusion support needed for implantation and explantation of cardiac assist devices. Because such devices are frequently used at this institution, we have established a protocol to support these patients. We reviewed blood bank records to document the usage of blood components in all patients on cardiac assist devices from 1989 to 2005 (n = 215). The data were separated into components given at the time of implantation and explantation of the device. Implantation data on 214 patients showed the mean use as follows: red blood cells (RBC), 5.7 U; platelets (PLT), 2.4 U; fresh frozen plasma (FFP), 7.5 U; and cryoprecipitate, 0 U. Explantation data on 134 patients showed a mean use as follows: RBC, 7.7 U; PLT, 2.4 U; FFP, 9.9 U; and cryoprecipitate, 3.7 U. Our protocol for the preparation of blood components for implantation and explantation of a cardiac device is, implantation: RBC, 4 U; PLT, 1 U; FFP, 6 U; explantation: RBC, 8 U; PLT, 2 U; FFP, 8 U. Our data do not support the need for preparation of cryoprecipitate before implantation or explantation.",
author = "Bartley, {Angela N.} and Redford, {Daniel T} and Berg, {Mary P.}",
year = "2007",
month = "5",
doi = "10.1097/MAT.0b013e318034095c",
language = "English (US)",
volume = "53",
pages = "320--323",
journal = "ASAIO Journal",
issn = "1058-2916",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Transfusion protocol for implantation and explantation of cardiac devices in an academic medical center

AU - Bartley, Angela N.

AU - Redford, Daniel T

AU - Berg, Mary P.

PY - 2007/5

Y1 - 2007/5

N2 - Few reports in the literature describe the transfusion support needed for implantation and explantation of cardiac assist devices. Because such devices are frequently used at this institution, we have established a protocol to support these patients. We reviewed blood bank records to document the usage of blood components in all patients on cardiac assist devices from 1989 to 2005 (n = 215). The data were separated into components given at the time of implantation and explantation of the device. Implantation data on 214 patients showed the mean use as follows: red blood cells (RBC), 5.7 U; platelets (PLT), 2.4 U; fresh frozen plasma (FFP), 7.5 U; and cryoprecipitate, 0 U. Explantation data on 134 patients showed a mean use as follows: RBC, 7.7 U; PLT, 2.4 U; FFP, 9.9 U; and cryoprecipitate, 3.7 U. Our protocol for the preparation of blood components for implantation and explantation of a cardiac device is, implantation: RBC, 4 U; PLT, 1 U; FFP, 6 U; explantation: RBC, 8 U; PLT, 2 U; FFP, 8 U. Our data do not support the need for preparation of cryoprecipitate before implantation or explantation.

AB - Few reports in the literature describe the transfusion support needed for implantation and explantation of cardiac assist devices. Because such devices are frequently used at this institution, we have established a protocol to support these patients. We reviewed blood bank records to document the usage of blood components in all patients on cardiac assist devices from 1989 to 2005 (n = 215). The data were separated into components given at the time of implantation and explantation of the device. Implantation data on 214 patients showed the mean use as follows: red blood cells (RBC), 5.7 U; platelets (PLT), 2.4 U; fresh frozen plasma (FFP), 7.5 U; and cryoprecipitate, 0 U. Explantation data on 134 patients showed a mean use as follows: RBC, 7.7 U; PLT, 2.4 U; FFP, 9.9 U; and cryoprecipitate, 3.7 U. Our protocol for the preparation of blood components for implantation and explantation of a cardiac device is, implantation: RBC, 4 U; PLT, 1 U; FFP, 6 U; explantation: RBC, 8 U; PLT, 2 U; FFP, 8 U. Our data do not support the need for preparation of cryoprecipitate before implantation or explantation.

UR - http://www.scopus.com/inward/record.url?scp=34249013363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249013363&partnerID=8YFLogxK

U2 - 10.1097/MAT.0b013e318034095c

DO - 10.1097/MAT.0b013e318034095c

M3 - Article

VL - 53

SP - 320

EP - 323

JO - ASAIO Journal

JF - ASAIO Journal

SN - 1058-2916

IS - 3

ER -